Praktično
Jelo u inostranstvu sa celijakijom ili alergijom na hranu
Jezička barijera pretvara upravljano stanje u kockanje. Rešenje je uglavnom logističko i vredi ga primeniti pre nego što odete.
Šta vam daju pravila EU
Četrnaest glavnih alergena — uključujući žitarice koje sadrže gluten — mora biti deklarisano širom EU, u pakovanoj hrani i u uslužnoj hrani. Pravila su dovoljno uniformna da putnik sa celijakijom koji se kreće između država članica ima isti okvir označavanja, što je značajna i nedovoljno cenjena prednost.
Ono što varira je sprovođenje, kako uslužna hrana otkriva (usmeno, na meniju, u fascikli) i kulturna upoznatost sa stanjem. Neke zemlje imaju visoku javnu svest o celijakiji; druge to tretiraju kao preferencu.
Praktični sistem
- Nabavite karticu za prevođenje na lokalnom jeziku, koja medicinski navodi stanje, imenuje šta treba izbegavati i pominje zajedničke friteze i površine. Kartica ide u kuhinju; izgovorena rečenica ne ide.
- Naučite da čitate spisak sastojaka, a ne jezik. Alergeni su tipografski naglašeni širom EU, tako da ih možete pronaći bez čitanja ostatka.
- Rezervišite smeštaj sa frižiderom i čajnikom. To pretvara teško putovanje u obično.
- Ponesite sigurnu hranu za dane putovanja. Aerodromi, stanice i duga putovanja su mesta gde ljudi bivaju uhvaćeni.
- Pronađite lokalnu celijak ili alergijsku asocijaciju. Većina evropskih zemalja ima jednu, nekoliko objavljuje liste mesta.
- Ponesite dovoljno lekova — uključujući auto-injektore adrenalina gde je to relevantno — i nosite pismo sa receptom.
Osiguranje i dokumentacija
Proverite da li putno osiguranje pokriva vaše stanje i nosite dokumentaciju o bilo kojim lekovima u originalnom pakovanju sa pismom sa receptom. Unutar EU, Evropska kartica zdravstvenog osiguranja pokriva neophodnu državnu zdravstvenu zaštitu, što nije isto kao putno osiguranje i ne zamenjuje ga.
Česta pitanja
Da li su kartice za prevođenje zaista korisne?
Da, više nego govor. Kartica se može predati kuhinji, što je mesto gde se donose odluke.
Koje evropske zemlje su najlakše za celijakiju?
Svest varira više nego regulativa. Nacionalna društva za celijakiju su najbolji trenutni izvor, a ne bilo kakva generalizacija.
Mogu li poneti svoje lekove preko granica?
Generalno da, u originalnom pakovanju sa pismom sa receptom. Proverite posebno kontrolisane supstance.
Šta ako se inostranstvu izložim glutenu?
Upravljajte simptomima i hidratacijom. Ne postoji tretman za izloženost — pogledajte naš celijak sajt.
Референце
Свака цитата испод води до оригиналног рецензираног записа на PubMed или преко DOI. Ништа овде није замена за медицински савет.
-
Selected laboratory-based biomarkers for assessing vitamin A deficiency in at-risk individuals Gannon BM, Huey SL, Mehta NH, et al. · The Cochrane database of systematic reviews · 2025 · Meta-analysis DOIPubMed 40433851Full text
-
Towards shortening the duration of antibiotic therapy for Lyme borreliosis: a systematic review and meta-analysis Raffetin A, Henningsson AJ, Ornstein K, et al. · Infection · 2025 · Meta-analysis DOIPubMed 40246800
-
Non-pharmacological interventions designed to support carriers of multi-drug-resistant organisms (MDROs): a systematic literature review Gaube S, Pan M, Rath A, et al. · The Journal of hospital infection · 2025 · Systematic review DOIPubMed 40816599
-
Risk of anaphylaxis on commercial flights Turner PJ · Current opinion in allergy and clinical immunology · 2025 · Systematic review DOIPubMed 40643054Full text
-
How Common Are Allergic Reactions During Commercial Flights? A Systematic Review and Meta-Analysis Turner PJ, Mamula J, Laktabi J, et al. · The journal of allergy and clinical immunology. In practice · 2023 · Meta-analysis DOIPubMed 37507067
-
Skin care interventions in infants for preventing eczema and food allergy Kelleher MM, Cro S, Cornelius V, et al. · The Cochrane database of systematic reviews · 2021 · Meta-analysis DOIPubMed 33545739Full text
-
The effectiveness of anti-inflammatory and anti-seizure medication for individuals with single enhancing lesion neurocysticercosis: A meta-analysis and expert group-based consensus recommendations Abraham A, Bustos JA, Carabin H, et al. · PLoS neglected tropical diseases · 2021 · Meta-analysis DOIPubMed 33788843Full text
-
Exit and Entry Screening Practices for Infectious Diseases among Travelers at Points of Entry: Looking for Evidence on Public Health Impact Mouchtouri VA, Christoforidou EP, An der Heiden M, et al. · International journal of environmental research and public health · 2019 · Systematic review DOIPubMed 31766548Full text
-
Frequency, severity and causes of unexpected allergic reactions to food: a systematic literature review Versluis A, Knulst AC, Kruizinga AG, et al. · Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2015 · Systematic review DOIPubMed 24766413
-
EAACI food allergy and anaphylaxis guidelines: managing patients with food allergy in the community Muraro A, Agache I, Clark A, et al. · Allergy · 2014 · Clinical guideline DOIPubMed 24905609
-
Source attribution of human campylobacteriosis using a meta-analysis of case-control studies of sporadic infections Domingues AR, Pires SM, Halasa T, et al. · Epidemiology and infection · 2012 · Meta-analysis DOIPubMed 22214729
-
Effects of pregnancy and lactation prebiotics supplementation on infant allergic disease: A randomized controlled trial Palmer DJ, Cuthbert AR, Sullivan TR, et al. · The Journal of allergy and clinical immunology · 2025 · Randomised controlled trial DOIPubMed 39173718
-
One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial Kliewer KL, Gonsalves N, Dellon ES, et al. · The lancet. Gastroenterology & hepatology · 2023 · Randomised controlled trial DOIPubMed 36863390Full text
-
Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial Jackson DJ, Bacharier LB, Gergen PJ, et al. · Lancet (London, England) · 2022 · Randomised controlled trial DOIPubMed 35964610Full text
-
Basophil Activation Test: Bridging Allergy and Oncology for Diagnostic, Therapeutic and Prognostic Applications in AllergoOncology: An EAACI Position Paper Pascal M, Chauhan J, Knol E, et al. · Allergy · 2025 · Review DOIPubMed 40503572Full text
-
The epithelial barrier theory and its associated diseases Sun N, Ogulur I, Mitamura Y, et al. · Allergy · 2024 · Review DOIPubMed 39370939Full text
-
Travel Medicine Leung DT, LaRocque RC, Ryan ET · Annals of internal medicine · 2018 · Review DOIPubMed 29297035
-
The restaurant syndromes Settipane GA · New England and regional allergy proceedings · 1987 · Review DOIPubMed 3302666
-
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092927Full text
-
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092926Full text
-
Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 The Lancet. Neurology · 2024 · Journal article DOIPubMed 39304265Full text
-
Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019 Shin YH, Hwang J, Kwon R, et al. · Allergy · 2023 · Journal article DOIPubMed 37431853Full text